Task: Answer the multiple-choice question.
Query: Which compound exhibits a -22.604\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. O=c1[nH]c(SCCOc2cccc3ccccc23)nc2ccccc12
b. Clc1ccc(-c2csc(=Nc3cccnc3)n2CCCn2ccnc2)cc1Cl
c. O=C(Nc1ccc(Cl)cc1)N(Cc1nc2ccccc2c(=O)[nH]1)Cc1cccs1
Answer: b. Clc1ccc(-c2csc(=Nc3cccnc3)n2CCCn2ccnc2)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(-c2csc(=Nc3cccnc3)n2CCCn2ccnc2)cc1Cl
Clc1ccc(-c2csc(=Nc3cccnc3)n2CCCn2ccnc2)cc1Cl
4-(3,4-dichlorophenyl)-3-(3-imidazol-1-ylpropyl)-N-pyridin-3-yl-1,3-thiazol-2-imine